Installed base looms large for PACS firmsAgfa's planned acquisition of most of Sterling Diagnostic Imaging's assets and Eastman Kodak's 1998 acquisition of Imation's medical imaging business revealed several important truths about the medical
Installed base looms large for PACS firms
Agfa's planned acquisition of most of Sterling Diagnostic Imaging's assets and Eastman Kodak's 1998 acquisition of Imation's medical imaging business revealed several important truths about the medical imaging and PACS marketplace. First, film market share is still crucial for the success of these firms.
Despite years of hype, market penetration of PACS technology remains at very low levels. The future is certainly digital for hospitals, but in today's market, film sales continue to provide an important revenue stream for these vendors.
In addition to providing profits today, a hefty film market share may also pay off down the road. By maintaining strong relationships with customers, film companies would likely have a leg up on other vendors for future sales of digital image management technology. In a complicated sales situation like PACS, relationships can make all the difference.
Although it did not acquire film market share, Access Radiology took a similar approach in acquiring installed base through its acquisition of fellow teleradiology firm EMED (PNN 12/98). That company hopes to leverage off EMED's stable of on-call teleradiology users for more advanced teleradiology implementations.
While it is too early to tell whether Agfa, Kodak, and Access will be successful in their efforts, it's hard to argue with their approaches. More often than not, customers will go with the company they know and believe they can trust.
--Erik L. Ridley, Editor
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.